{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:39:45Z","timestamp":1787668785832,"version":"build-2736575974"},"reference-count":16,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100007301","name":"Harvard University Center for AIDS Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007301","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["P30 AI060354"],"award-info":[{"award-number":["P30 AI060354"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Long-acting injectable cabotegravir (CAB-LA) is highly efficacious as PrEP and could increase PrEP coverage, though uptake has been limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We surveyed healthcare professionals regarding experiences with CAB-LA implementation in the United States. We used descriptive statistics to summarize perceived barriers and Fisher\u2019s exact tests to assess for factors associated with CAB-LA availability and use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among respondents, 71% (51\/72) reported their clinic site offered CAB-LA though only 44% (20\/45) reported having prescribed it. The most common perceived barriers were concerns about insurance coverage (38\/45, 84%), logistics (35\/45, 78%), lack of requests (32\/45, 71%), concern for missed injections (17\/25, 68%), and cost (16\/25, 64%). A majority (30\/45, 67%) felt that lack of training was a barrier. Availability and prescribing did not vary by demographic or patient panel characteristics (p-values&gt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Healthcare professionals\u2019 perceived barriers to CAB-LA uptake suggest need for improved implementation strategies, specifically surrounding cost, logistics, and education.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23259582261471981","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:53:11Z","timestamp":1784724791000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Health Care Providers\u2019 Experiences With and Perceived Barriers to Implementation of Long-Acting Injectable HIV Preexposure Prophylaxis: A Cross-Sectional Survey"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1890-860X","authenticated-orcid":false,"given":"Elena","family":"Beideck","sequence":"first","affiliation":[{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gould","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Krakower","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center"},{"name":"The Fenway Institute"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"e_1_3_8_2_2","unstructured":"Centers for Disease Control and Prevention. Data Table: Monitoring National HIV Prevention Goals. 2025. https:\/\/www.cdc.gov\/hiv-data\/initiatives\/prevention-goals-table.html. Accessed August 27 2025."},{"key":"e_1_3_8_3_2","unstructured":"Centers for Disease Control and Prevention. Ending the HIV Epidemic in the US Goals. Published March 20 2024. https:\/\/www.cdc.gov\/ehe\/php\/about\/goals.html. Accessed August 27 2025."},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00538-4"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac716"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26497"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10352-w"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"e_1_3_8_11_2","unstructured":"U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation. National Uninsured Rate Reaches an All-Time Low in Early 2023. 2023. Accessed August 27 2025.https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/e06a66dfc6f62afc8bb809038dfaebe4\/Uninsured-Record-Low-Q12023.pdf"},{"key":"e_1_3_8_12_2","volume-title":"Health Insurance Coverage in the United States: 2023","author":"U.S. Census Bureau","year":"2024","unstructured":"U.S. Census Bureau. Health Insurance Coverage in the United States: 2023. U.S. Census Bureau; 2024. https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2023\/demo\/p60-281.pdf. Accessed August 27, 2025."},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2023.00502"},{"key":"e_1_3_8_14_2","unstructured":"ViiV Healthcare. APRETUDE (cabotegravir) U.S. pricing information. https:\/\/viivuspricing.com\/apretude.html. Updated January 1 2026. Accessed March 24 2026."},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/23259582241234567"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003695"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2025.00037"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261471981","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23259582261471981","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261471981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T01:46:34Z","timestamp":1785030394000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23259582261471981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":16,"alternative-id":["10.1177\/23259582261471981"],"URL":"https:\/\/doi.org\/10.1177\/23259582261471981","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"23259582261471981"}}